Abstracts tagged "African-Americans and systemic lupus erythematosus (SLE)"

Abstract Number: 1144 • 2019 ACR/ARP Annual Meeting
Understanding Clinical Trials Participation Among Individuals of African Descent with Lupus Through the Lens of Critical Race Theory: A Qualitative Analysis
Candace Feldman¹, Jessica Williams ¹, Courtnie Phillip ¹, Corine Sinnette ¹, Karen Mancera-Cuevas ², Patricia Canessa ³, Gina Curry ⁴, Maryann Mason ² and Rosalind Ramsey-Goldman ², ¹Brigham and Women's Hospital, Boston, MA, ²Northwestern University, Chicago, IL, ³IPHA, Chicago, IL, ⁴University of Chicago, Chicago, IL
Background/Purpose: Despite a disproportionate burden of lupus and poorer outcomes among individuals of African descent (hereafter “black”) compared to white individuals, black individuals are underrepresented…
Abstract Number: 1235 • 2015 ACR/ARHP Annual Meeting
Epidemiology of Kikuchi-Fujimoto Disease in Martinique and Characteristics in an Afro-Caribbean Population: Close Relation with Lupus
Florence MOINET¹, Vincent MOLINIE², Katlyne Polomat¹, Nadege Cordel³, Guillaume BERAUD⁴, Dominique SAINTE MARIE⁵, Olivier DUFFAS⁶, Charlène BOMAHOU⁷, Serge ARFI¹, Jean-come MENIANE⁸, Suzy DUFLO⁹, Yves HATCHUEL¹⁰ and Christophe Deligny¹, ¹Rheumatology and Internal Medicine, Zobda Quitman Hospital, Fort de France, Martinique, ²pathology, Zobda Quitman Hospital, Fort de France, Martinique, ³Infectious diseases, dermatology and internal medicine, Centre Hospitalier universitaire de Guadeloupe, Pointe à Pitre, Guadeloupe, ⁴Internal medicine and infectious disease, CHU de Poitiers, Poitiers, France, ⁵Dermatologie, Centre Hospitalier André Rosemon, Cayenne, French Guiana, ⁶ENT, Zobda Quitman Hospital, Fort de France, Martinique, ⁷Internal medicine, Hopital Européen Georges Pompidou, Paris, France, ⁸Hematology, Zobda Quitman Hospital, Fort de France, Martinique, ⁹ENT, Centre Hospitalier universitaire de Guadeloupe, Pointe à Pitre, Guadeloupe, ¹⁰Pediatry, Zobda Quitman Hospital, Fort de France, Martinique
Background/Purpose: Kikuchi-Fujimoto disease (KFD) is a rare histiocytic necrotizing lymphadenitis affecting mainly Asian young women, associated to systemic lupus (SLE) in less than 25% of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].